help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richter, J.
Right arrow Articles by Sauter, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richter, J.
Right arrow Articles by Sauter, G.
(American Journal of Pathology. 1998;153:1615-1621.)
© 1998 American Society for Investigative Pathology


Regular Articles

Patterns of Chromosomal Imbalances in Advanced Urinary Bladder Cancer Detected by Comparative Genomic Hybridization

Jan Richter* , Lorenza Beffa* , Urs Wagner* , Peter Schraml* , Thomas C. Gasser{dagger} , Holger Moch* , Michael J. Mihatsch* and Guido Sauter*

From the Institute of Pathology* and Urologic Clinics,{dagger} University of Basel, Basel, Switzerland

To identify genetic changes linked to bladder cancer progression we analyzed 90 invasive transitional cell carcinomas (37 pT1 and 53 pT2–4) by comparative genomic hybridization. The most frequent alterations included 1q+ (37%), 5p+ (24%), 6q- (19%), 8p- (29%), 8q+ (37%), 9p- (31%), 9q- (23%), 11p- (24%), 11q- (22%), 17q+ (29%), and 20q+ (28%). Interestingly, there were three groups of alterations that frequently occurred together (9p- and 11q13+/20q+ and 11q13+ or 17q+/1q+ and 3p+ or 11q-). These loci might carry genes that interact with each other in specific molecular pathways. There were remarkable genetic similarities between minimally and deeply invasive tumors of different histological grades, including a similar number of aberrations per tumor and an equal frequency of most individual alterations. However, deletions of 5q, 6q, and 15q and gains of 5p, 7p, and Xq were significantly more frequent in pT2–4 than in pT1 carcinomas. These loci may harbor genes that are important for bladder cancer progression.





This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
G. C Santos, M Zielenska, M Prasad, and J A Squire
Chromosome 6p amplification and cancer progression
J. Clin. Pathol., January 1, 2007; 60(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. A. Knowles
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
Carcinogenesis, March 1, 2006; 27(3): 361 - 373.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. D. Raman, N. P. Mongan, S. K. Tickoo, S. A. Boorjian, D. S. Scherr, and L. J. Gudas
Increased Expression of the Polycomb Group Gene, EZH2, in Transitional Cell Carcinoma of the Bladder
Clin. Cancer Res., December 15, 2005; 11(24): 8570 - 8576.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Koed, C. Wiuf, L.-L. Christensen, F. P. Wikman, K. Zieger, K. Moller, H. von der Maase, and T. F. Orntoft
High-Density Single Nucleotide Polymorphism Array Defines Novel Stage and Location-Dependent Allelic Imbalances in Human Bladder Tumors
Cancer Res., January 1, 2005; 65(1): 34 - 45.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Zheng, R. Simon, M. Mirlacher, R. Maurer, T. Gasser, T. Forster, P. A. Diener, M. J. Mihatsch, G. Sauter, and P. Schraml
TRIO Amplification and Abundant mRNA Expression Is Associated with Invasive Tumor Growth and Rapid Tumor Cell Proliferation in Urinary Bladder Cancer
Am. J. Pathol., July 1, 2004; 165(1): 63 - 69.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. J. Evans, B. L. Gallie, M. A.S. Jewett, G. R. Pond, K. Vandezande, J. Underwood, Y. Fradet, G. Lim, P. Marrano, M. Zielenska, et al.
Defining a 0.5-Mb Region of Genomic Gain on Chromosome 6p22 in Bladder Cancer by Quantitative-Multiplex Polymerase Chain Reaction
Am. J. Pathol., January 1, 2004; 164(1): 285 - 293.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. A. Veltman, J. Fridlyand, S. Pejavar, A. B. Olshen, J. E. Korkola, S. DeVries, P. Carroll, W.-L. Kuo, D. Pinkel, D. Albertson, et al.
Array-based Comparative Genomic Hybridization for Genome-Wide Screening of DNA Copy Number in Bladder Tumors
Cancer Res., June 1, 2003; 63(11): 2872 - 2880.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. O. Hoque, C.-C. R. Lee, P. Cairns, M. Schoenberg, and D. Sidransky
Genome-Wide Genetic Characterization of Bladder Cancer: A Comparison of High-Density Single-Nucleotide Polymorphism Arrays and PCR-based Microsatellite Analysis
Cancer Res., May 1, 2003; 63(9): 2216 - 2222.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. E. Moore, A. H. Smith, C. Eng, D. Kalman, S. DeVries, V. Bhargava, K. Chew, D. Moore II, C. Ferreccio, O. A. Rey, et al.
Arsenic-Related Chromosomal Alterations in Bladder Cancer
J Natl Cancer Inst, November 20, 2002; 94(22): 1688 - 1696.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. Sen, H. Zhou, R.-D. Zhang, D. S. Yoon, F. Vakar-Lopez, S. Ito, F. Jiang, D. Johnston, H. B. Grossman, A. C. Ruifrok, et al.
Amplification/Overexpression of a Mitotic Kinase Gene in Human Bladder Cancer
J Natl Cancer Inst, September 4, 2002; 94(17): 1320 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Dominguez, J. Carballido, J. Silva, J. M. Silva, J. M. Garcia, J. Menendez, M. Provencio, P. Espana, and F. Bonilla
p14ARF Promoter Hypermethylation in Plasma DNA as an Indicator of Disease Recurrence in Bladder Cancer Patients
Clin. Cancer Res., April 1, 2002; 8(4): 980 - 985.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Primdahl, F. P. Wikman, H. von der Maase, X.-g. Zhou, H. Wolf, and T. F. Orntoft
Allelic Imbalances in Human Bladder Cancer: Genome-Wide Detection With High-Density Single-Nucleotide Polymorphism Arrays
J Natl Cancer Inst, February 6, 2002; 94(3): 216 - 223.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
T. F. Orntoft, T. Thykjaer, F. M. Waldman, H. Wolf, and J. E. Celis
Genome-wide Study of Gene Copy Numbers, Transcripts, and Protein Levels in Pairs of Non-invasive and Invasive Human Transitional Cell Carcinomas
Mol. Cell. Proteomics, January 1, 2002; 1(1): 37 - 45.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Hoglund, T. Sall, S. Heim, F. Mitelman, N. Mandahl, and I. Fadl-Elmula
Identification of Cytogenetic Subgroups and Karyotypic Pathways in Transitional Cell Carcinoma
Cancer Res., November 1, 2001; 61(22): 8241 - 8246.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
M A Knowles
What we could do now: molecular pathology of bladder cancer
Mol. Pathol., August 1, 2001; 54(4): 215 - 221.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Simon, J. Richter, U. Wagner, A. Fijan, J. Bruderer, U. Schmid, D. Ackermann, R. Maurer, G. Alund, H. Knonagel, et al.
High-Throughput Tissue Microarray Analysis of 3p25 (RAF1) and 8p12 (FGFR1) Copy Number Alterations in Urinary Bladder Cancer
Cancer Res., June 1, 2001; 61(11): 4514 - 4519.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Simon, E. Eltze, K.-L. Schäfer, H. Bürger, A. Semjonow, L. Hertle, B. Dockhorn-Dworniczak, H.-J. Terpe, and W. Böcker
Cytogenetic Analysis of Multifocal Bladder Cancer Supports a Monoclonal Origin and Intraepithelial Spread of Tumor Cells
Cancer Res., January 1, 2001; 61(1): 355 - 362.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
M. Muscheck, H. Abol-Enein, K. Chew, D. Moore II, V. Bhargava, M.A. Ghoneim, P.R. Carroll, and F.M. Waldman
Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization
Carcinogenesis, September 1, 2000; 21(9): 1721 - 1726.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Richter, U. Wagner, J. Kononen, A. Fijan, J. Bruderer, U. Schmid, D. Ackermann, R. Maurer, G. Alund, H. Knonagel, et al.
High-Throughput Tissue Microarray Analysis of Cyclin E Gene Amplification and Overexpression in Urinary Bladder Cancer
Am. J. Pathol., September 1, 2000; 157(3): 787 - 794.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. J. Grippo and E. P. Sandgren
Highly Invasive Transitional Cell Carcinoma of the Bladder in a Simian Virus 40 T-Antigen Transgenic Mouse Model
Am. J. Pathol., September 1, 2000; 157(3): 805 - 813.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Bruch, W. A. Schulz, J. Häussler, I. Melzner, S. Brüderlein, P. Möller, R. Kemmerling, W. Vogel, and H. Hameister
Delineation of the 6p22 Amplification Unit in Urinary Bladder Carcinoma Cell Lines
Cancer Res., August 1, 2000; 60(16): 4526 - 4530.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
J. W. Gray and C. Collins
Genome changes and gene expression in human solid tumors
Carcinogenesis, March 1, 2000; 21(3): 443 - 452.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Richter, U. Wagner, P. Schraml, R. Maurer, G. Alund, H. Knonagel, H. Moch, M. J. Mihatsch, T. C. Gasser, and G. Sauter
Chromosomal Imbalances Are Associated with a High Risk of Progression in Early Invasive (pT1) Urinary Bladder Cancer
Cancer Res., November 1, 1999; 59(22): 5687 - 5691.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Toma, D. Hauri, U. Schmid, D. Ackermann, R. Maurer, G. Alund, H. Knonagel, M. Rist, T. C. Gasser, G. Sauter, et al.
Focal Loss of CD44 Variant Protein Expression is Related to Recurrence in Superficial Bladder Carcinoma
Am. J. Pathol., November 1, 1999; 155(5): 1427 - 1432.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Zhao, J. Richter, U. Wagner, B. Roth, P. Schraml, T. Zellweger, D. Ackermann, U. Schmid, H. Moch, M. J. Mihatsch, et al.
Chromosomal Imbalances in Noninvasive Papillary Bladder Neoplasms (pTa)
Cancer Res., September 1, 1999; 59(18): 4658 - 4661.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.